Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) was upgraded by equities research analysts at UBS Group to a "strong-buy" rating in a research note issued to investors on Wednesday, Zacks.com reports.
Separately, JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $7,400.00.
View Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
OTCMKTS:RBGLY traded down $0.14 on Wednesday, reaching $12.24. 483,230 shares of the company's stock were exchanged, compared to its average volume of 347,717. Reckitt Benckiser Group has a 52 week low of $10.24 and a 52 week high of $15.03. The stock has a fifty day simple moving average of $11.37 and a 200-day simple moving average of $11.35.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
